Krina K.
Krina K.
Circulating tumor cells (CTCs) are a blistering topic of oncological conferences and research due to their tremendous potential in the area of cancer diagnosis as well as treatment.
Prolymphocytic leukemia (PLL) is a very rare subtype of chronic leukemia. Although most forms of chronic leukemia progress slowly, PPL is often aggressive and can be difficult to treat.
Scientists Dr. Cristina Puig-Saus and Dr.
Senescent immune system cells are potentially among the most harmful of all senescent cells because they spread tissue damage and rapid aging across other body organs and systems. That is what a team of NIA-supported scientists at the University of Minnesota Medical School discovered through research using a mouse model that accelerated immune system aging by hindering DNA repair. The team recently published these findings in Nature.
Leukemia is a group of cancers that affect your bone marrow and cause your body to produce abnormal blood cells. Acute myeloid leukemia (AML) is the most common type of leukemia in adults and accounts for about 4 out of 5 adult cases. Acute monocytic leukemia (AML-M5) is a subtype of AML, in which at least 80 percent of the affected blood cells are a type of white blood cell called monocytes
Aging-US published "PirB functions as an intrinsic suppressor in hippocampal neural stem cells" which reported that neural stem cells play pivotal roles during prenatal development and throughout life. PirB expression increased with age during development, and its deficiency promoted neural stem cell proliferation and differentiation in vivo and in vitro
Clinical Trials Arena speaks to Lineage Cell Therapeutics CEO Brian Culley about the firms lead candidate OpRegen for dry AMD and the unexpected cases of retinal restoration in an ongoing Phase I/IIa trial. Age-related macular degeneration (AMD) is one of the worlds leading causes of blindness in people over the age of 50. There are two types of the disease wet AMD and dry AMD
Multiple sclerosis is an autoimmune disease that can affect the brain and spinal cord, and it is estimated that 130,000 people in the UK have the condition. There are drugs available to slow the onset of symptoms but treatment options for progressive MS are limited and there is currently no cure.
The cute baby mice in a Kyushu University lab may appear relatively normal. But they are, however, a scientific marvel. Like Frankensteins monster, the mice were bioengineered
Recent Comments